Press Releases
Public Relations: Andrew Noble
DNAnexus Honored with Frost & Sullivan’s 2025 Technology Innovation Leadership Award
DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care
DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion
DNAnexus & Boehringer Ingelheim Named 2025 Prix Galien USA Nominee in Best Digital Health Solution for Project PRISM/Project CRYPTx
ARPA-H pioneers game-changing cancer care designed to adapt throughout treatment
Latin-American genetic data available securely to approved researchers worldwide
DNAnexus Announces Collaboration with AlidaBio to Enhance RNA Modification and Expression Analysis
AlidaBio EpiPlex™ customers now have cloud access to the EpiScout™ analysis software on DNAnexus’ secure, scalable precision health data cloud platform
DNAnexus Expands Relationship with Veeva to Advance Global Regulatory Collaboration
DNAnexus Recognized by Frost & Sullivan for Ability to Integrate and Synchronize Diverse Clinical and Multi-omics Data
DNAnexus and Panomics Join Forces to Deliver Comprehensive, Interactive Multi-omics Data Solutions for Biopharma Organizations
Researchers can conduct large-scale transcriptomics and proteomics data analyses on secure, cloud-based platform to accelerate biomarker discovery and drug repurposing applications.
News
DNAnexus and Oracle Health to Integrate Genomic Data into Clinical Care
DNAnexus, Oracle Partner to Link Genomic Data to Electronic Health Records
People in the News at DNAnexus, Astrin Biosciences
In Brief This Week: Tempus AI, Myriad Genetics, 23andMe, DNAnexus, Dovetail Genomics
2025 Trends: Multiomics
DNAnexus, Panomics Partner to Offer Multiomics Data Analysis Platform for Biopharma Researchers
The Rise and Importance of Population-Scale Genome Programs
With the wealth of population-scale projects going on, we have entered a golden age of genomics. Based on efforts such as the All of Us program in the U.S. and the UK Biobank, among many others, we are poised to discover more than we ever knew about natural genetic diversity, what’s considered “normal” human biology, and the continuum of health and disease.
World’s largest genetic project opens the door to new era for treatments and cures: UK Biobank’s major milestone
In a momentous landmark for medical research, UK Biobank has today unveiled incredible new data from whole genome sequencing of its half a million participants. This is set to drive the discovery of new diagnostics, treatments and cures and, uniquely, is available to approved researchers worldwide, via a protected database containing only de-identified data (e.g. name, address, date of birth, name of GP and more stripped out).
DNAnexus included in Fast Company's 10 most innovative biotech companies of 2023
Among the 2023 Most Innovative Companies in Biotech, Fast Company is recognizing breakthroughs in DNA sequencing and spatial transcriptomics, along with innovations in biological-specimen sourcing, cell-separation technology, and the production of synthetic antibodies.
Blackstone Growth Leads $200 Million Investment in DNAnexus
"Collaboration is vital to advancing scientific discovery. We are excited to partner with Microsoft and DNAnexus to create infrastructure and tools to share data and accelerate progress toward finding cures for pediatric cancer and other life-threatening diseases."
James R. Downing
President & CEO
St. Judes Children’s Research Hospital